Galapagos NV
GLPG
#4540
Rank
โ‚น204.59 B
Marketcap
โ‚น3,105
Share price
-0.73%
Change (1 day)
57.19%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -โ‚น46.41 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚น0.32 Billion. In 2024 the company made an earning of -โ‚น0.53 Billion, an increase over its 2023 earnings that were of -โ‚น3.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น46.41 Billion8662.71%
2024 -โ‚น0.53 Billion-82.77%
2023 -โ‚น3.08 Billion-85.59%
2022 -โ‚น21.34 Billion60.71%
2021 -โ‚น13.28 Billion-60.08%
2020 -โ‚น33.26 Billion-331.44%
2019 โ‚น14.36 B-523.76%
2018 -โ‚น3.4 Billion-72.34%
2017 -โ‚น12.27 Billion-329.59%
2016 โ‚น5.34 B-144.3%
2015 -โ‚น12.06 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.968 T-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น745.77 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น152.12 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น833.95 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น2.115 T-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.199 T-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น854.35 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น4.91 Billion-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น162.38 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel